The COVID-19 pandemic has now been underway for more than a year and a half. In that time, we've learned a lot about vaccine development and distribution. This article from statnews.com summarizes some the things that will help us with future pandemics.
The world got very lucky; so much went right in the quest for vaccines to end this pandemic. But there have been setbacks (see: Sanofi) and failures (see: Merck) along the way, and the progress toward supplying vaccine to less affluent parts of the world has been scandalously slow.
As life begins to return to normal — at least in countries with access to vaccines — STAT wanted to take stock of some of the things that worked in the fast-tracked development of vaccines and some of the things that didn’t. Interviews with a number of experts in immunology, drug development, and government research revealed a dozen lessons we should learn from the Covid vaccine project for next time. Sadly, there will be a next time.
I think I'm going to forward this link to my provincial and federal representatives.
No comments:
Post a Comment